Form 4: USPH COO Sells Shares Under 10b5-1 Plan

U.S. Physical Therapy COO Graham D. Reeve sold 763 shares of common stock for approximately $84.97 per share under a pre-arranged plan.

Summary

• Graham D. Reeve, Chief Operating Officer of U.S. Physical Therapy Inc. (USPH), reported a sale of common stock.
• The transaction involved 763 shares sold at a weighted average price of $84.97 per share, with prices ranging from $84.90 to $85.02.
• The sale occurred on August 21, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
• Following the sale, Reeve directly owns 21,483 shares and indirectly owns 1,808 shares through the Reeve Trust, totaling 23,291 shares.
• Direct holdings include 15,296 restricted shares granted under the Company's Amended and Restated 2003 Stock Incentive Plan, with vesting dates extending through March 6, 2029, contingent on continued employment.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction disclosure (Form 4). While it's a sale, the indication of a 10b5-1 plan suggests it's a pre-scheduled event rather than a reaction to new negative information. The amount sold is also relatively small compared to total holdings, and significant restricted stock holdings remain.

Negatives

• A company insider, the Chief Operating Officer, sold 763 shares of common stock.

Risks

• The vesting of 15,296 restricted shares for the COO is contingent on continued employment with the company, posing a risk to the employee if employment ceases before vesting dates.

Future Outlook

Future vesting of restricted stock for the COO is scheduled through March 2029, contingent on continued employment, suggesting a long-term retention strategy for key management.

Industry Context

This transaction is a routine insider trading disclosure for a publicly traded company in the physical therapy sector. Insider sales can occur for various personal financial planning reasons, including tax management or diversification, and are often pre-scheduled under Rule 10b5-1 plans, as indicated by the check box.

Comparison to Industry Standards

• Insider sales are common across all industries. The sale of 763 shares by the COO of U.S. Physical Therapy Inc. is a relatively small percentage of his total beneficial ownership (23,291 shares), which is not uncommon for personal liquidity or diversification purposes.
• Companies like Select Medical Holdings Corporation (SEM) or ATI Physical Therapy, Inc. (ATIP) also have similar insider transaction disclosures regularly.

Stakeholder Impact

• Shareholders: The sale by a key executive could be perceived negatively, but the small volume and 10b5-1 plan context mitigate this.
• Employees: The continued vesting schedule for the COO's restricted stock indicates a long-term commitment, which could be positive for employee morale.

Next Steps

• Continued vesting of COO's restricted stock holdings through March 6, 2029, contingent on employment.

Key Dates

Recommendation

The filing details a routine insider stock sale by the COO, which appears to be pre-planned under a 10b5-1 plan. The volume of shares sold is relatively small compared to the executive's total beneficial ownership, and significant restricted stock holdings with future vesting dates remain. This transaction does not indicate a fundamental change in the company's prospects or the executive's long-term commitment, thus a 'hold' recommendation is appropriate as this filing alone does not provide a strong signal for buying or selling.

Keywords

USPH, U.S. Physical Therapy, Graham D. Reeve, Insider Sale, Form 4, SEC Filing, Stock Transaction, COO, Restricted Stock, 10b5-1 Plan